PharmInvent's Global Pharmacovigilance Network Expands to MENA Region

Aug 5, 2015

With the increased movement of Multi-national Pharmaceutical companies into new regions, PharmInvent has begun offering its internationally recognized pharmacovigilance and regulatory services in the MENA region and gulf countries.  The initial projects will be for a long standing client who has requested a local contact persons for pharmacovigilance (LCPPV) in the countries of:

  • Bahrain
  • Qatar
  • Jordan
  • Saudi Arabia
  • Oman
  • Kuwait
  • United Arab Emirates

In addition to the LCPPV services, PharmInvent through their local partners will be providing local literature search and monitoring services in the same way that these services have been provided to all existing clients since the company’s inception. 

With many major changes taking place in the Arab Countries in the near future, changes such as the gradual adoption of the “Guideline On Good Pharmacovigilance Practice for Arab Countries” which began its implementation on July 1st, 2015, the time has come for PharmInvent to bring PV options to existing and new clients in this region.

In the coming weeks and months, you can expect to see continual expansion into new regions of the world by PharmInvent.  The opportunity to raise the standard of LCPPV services worldwide is an ongoing motivational factor that directly benefits PharmInvent clients, patients, and National Competent Authorities daily.

Back to previous page...